Hisamitsu Pharmaceutical Co Inc (HTSUF)
24.56
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Hisamitsu Pharmaceutical Debt to Equity Ratio: 0.0043 for Feb. 29, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
February 29, 2024 | 0.0043 |
November 30, 2023 | 0.0043 |
August 31, 2023 | 0.0043 |
May 31, 2023 | 0.0046 |
February 28, 2023 | 0.0048 |
November 30, 2022 | 0.0046 |
August 31, 2022 | 0.0047 |
May 31, 2022 | 0.0051 |
February 28, 2022 | 0.0051 |
November 30, 2021 | 0.0053 |
August 31, 2021 | 0.0053 |
May 31, 2021 | 0.0054 |
February 28, 2021 | 0.0056 |
November 30, 2020 | 0.006 |
August 31, 2020 | 0.006 |
May 31, 2020 | 0.0063 |
February 29, 2020 | 0.0063 |
November 30, 2019 | 0.0066 |
August 31, 2019 | 0.0069 |
May 31, 2019 | 0.0072 |
February 28, 2019 | 0.0073 |
November 30, 2018 | 0.0073 |
August 31, 2018 | 0.0076 |
May 31, 2018 | 0.008 |
February 28, 2018 | 0.0081 |
Date | Value |
---|---|
November 30, 2017 | 0.0084 |
August 31, 2017 | 0.0092 |
May 31, 2017 | 0.0092 |
February 28, 2017 | 0.0094 |
November 30, 2016 | 0.0104 |
August 31, 2016 | 0.0103 |
May 31, 2016 | 0.0102 |
February 29, 2016 | 0.0104 |
November 30, 2015 | 0.0103 |
August 31, 2015 | 0.0102 |
May 31, 2015 | 0.0112 |
February 28, 2015 | 0.0109 |
November 30, 2014 | 0.0118 |
August 31, 2014 | 0.0123 |
May 31, 2014 | 0.0129 |
February 28, 2014 | 0.0129 |
November 30, 2013 | 0.0136 |
August 31, 2013 | 0.0143 |
May 31, 2013 | 0.0149 |
February 28, 2013 | 0.0159 |
November 30, 2012 | 0.0177 |
August 31, 2012 | 0.0183 |
May 31, 2012 | 0.0364 |
February 29, 2012 | 0.0382 |
November 30, 2011 | 0.0584 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0043
Minimum
Aug 2023
0.0072
Maximum
May 2019
0.0054
Average
0.0053
Median
Aug 2021
Debt to Equity Ratio Benchmarks
Takeda Pharmaceutical Co Ltd | 0.666 |
Nxera Pharma Co Ltd | 1.027 |
PeptiDream Inc | 0.5396 |
Healios KK | 1.196 |
AnGes Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 2.182B |
Total Liabilities (Quarterly) | 409.58M |
Shareholders Equity (Quarterly) | 1.758B |
Current Ratio | 4.224 |
Net Debt Paydown Yield | 0.01% |